• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Infectious Disease

Risk of hospitalization for COVID-19 higher among black patients in Atlanta, Georgia

byBrian DoughertyandAlex Chan
June 21, 2020
in Infectious Disease, Public Health, Pulmonology
Reading Time: 2 mins read
Herpes simplex virus infection uncommon in infants undergoing meningitis evaluation
Share on FacebookShare on Twitter

1. Black patients with COVID-19 were more likely to be hospitalized than white patients in Atlanta, Georgia.

2. Older age adults, lack of health insurance, male sex, obesity, smoking, and diebetes mellitus history were also found to be at an independently increased risk of hospitalization.

Evidence Rating Level: 2 (Good)

Study Rundown: To date, over 2 million cases of COVID-19 have been reported in the United States. There is a growing body of literature to suggest that older populations, males, black patients, and individuals with significant underlying medical conditions are at an increased risk of infection and adverse outcomes. Comparatively less is known about the risk for hospitalization among these specific groups. This cross-sectional study compared hospitalized and non-hospitalized adults from the Atlanta, Georgia, area to identify risk factors associated with hospitalization. Among this population, age ≥65 years, black race, having a diagnosis of diabetes mellitus, lack of health insurance, male sex, smoking, and obesity were all independently associated with an increased risk of hospitalization. The association between black individuals and hospitalization persisted after controlling for diagnosed medical conditions, suggesting that underlying structural mechanisms like access to health care and other social determinants of health played a role in this increased risk. An inherent limitation of this report, like many other cross-sectional studies, is selection bias; for example, non-hospitalized individuals might have chosen to not seek care or to seek care elsewhere. Therefore, hospitalization itself may be representative of potential confounding variables that have influenced the data. Nonetheless, this report further characterizes the persistent, yet recently exacerbated, health disparities that exist in the United States and adds to the growing consensus that specific populations are, in addition to adverse outcomes, at an independently increased risk for hospitalization due to COVID-19.

Click here to read the study in MMWR

Relevant reading: COVID-19 and Racial/Ethnic Disparities

RELATED REPORTS

Ensitrelvir associated with reduced risk of Covid-19 among household contacts

Delayed initiation of antibiotic therapy is associated with worse outcomes in skin and soft tissue infections

Polypharmacy is associated with higher risk of mortality and hospitalizations among older adults

In-depth [cross-sectional study]: The study population included 220 hospitalized (median age = 61.0 years, 51.8% male, 79.1% black) and 311 non-hospitalized (median age = 45.0 years, 36.7% male, 44.7% black) in the metropolitan Atlanta, Georgia, area between 1 March and 7 April 2020. Hospitals provided lists of patients from which the study cohort participants were sequentially selected. Participants were all ≥18 years with RT-PCR laboratory-confirmed COVID-19 and treated at six acute care hospitals or their respective outpatient clinics. After controlling for baseline patient characteristics and comorbidities, age ≥65 years (aOR 3.4, 95% CI 1.6 to 7.4), black race (aOR 3.2, 95% CI 1.8 to 5.8), having a diagnosis of diabetes mellitus (aOR 3.1, 95% CI 1.7 to 5.9), lacking health insurance (aOR = 2.8, 95% CI 1.1 to 7.3), male sex (aOR = 2.4, 95% CI 1.4 to 4.1), smoking (aOR 2.3, 95% CI 1.2 to 4.5), and obesity (aOR = 1.9, 95% CI 1.1 to 3.3) were all independently associated with an increased risk of hospitalization. Among this particular cohort, hypertension, which has previously been described as associated with poorer outcomes, was not correlated with an increased risk of hospitalization. Additional research is needed to characterize the public health and health policy implications of these data.

Image: PD

©2020 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: blackCoronavirushospitalizationSARS-CoV-2
Previous Post

Factors related to suicide and burnout among physicians

Next Post

#VisualAbstract: Randomized Trial of Lactin-V to Prevent Recurrence of Bacterial Vaginosis

RelatedReports

Novel coronavirus identified from patients with pneumonia in Wuhan, China
Infectious Disease

Ensitrelvir associated with reduced risk of Covid-19 among household contacts

May 26, 2026
Transthoracic echocardiography can rule out endocarditis in low-risk bacteremic patients
Infectious Disease

Delayed initiation of antibiotic therapy is associated with worse outcomes in skin and soft tissue infections

May 22, 2026
Quick Take: The clinical effectiveness of sertraline in primary care and the role of depression severity and duration (PANDA): a pragmatic, double-blind, placebo-controlled randomized trial
Chronic Disease

Polypharmacy is associated with higher risk of mortality and hospitalizations among older adults

February 10, 2026
Steroids and opioids often inappropriately prescribed in the emergency department for pediatric pneumonia and sinusitis
Public Health

Trends in firearm-related hospitalizations and deaths in New Zealand

September 22, 2025
Next Post
#VisualAbstract: Randomized Trial of Lactin-V to Prevent Recurrence of Bacterial Vaginosis

#VisualAbstract: Randomized Trial of Lactin-V to Prevent Recurrence of Bacterial Vaginosis

Long-term outcomes for off-pump and on-pump CABG are similar

Deterioration of left ventricular ejection fraction to mid-range ejection fraction associated with increased mortality and cardiovascular events

2 Minute Medicine Rewind June 22, 2020

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Nirsevimab (Beyfortus) may reduce severe respiratory syncytial virus infections among infants
  • An artificial intelligence (AI) tool achieved high diagnostic accuracy for the identification and prediction of sepsis
  • Use of long-acting broadly neutralizing antibodies may delay human immunodeficiency virus (HIV) rebound following discontinuation of antiretroviral therapy
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.